3,823,982 Ordinary Shares of ABIONYX Pharma SA are subject to a Lock-Up Agreement Ending on 7-DEC-2022. These Ordinary Shares will be under lockup for 365 days starting from 7-DEC-2021 to 7-DEC-2022.

Details:
In the same way as Messrs. Emmanuel HUYNH and Cyrille TUPIN, subscribers to the capital increase in cash, Messrs. Pierre-Paul ELENA and Yann QUENTRIC, partners in the transfer to the company of 100% of the capital of IRIS Pharma holding which holds 100% of Iris Pharma, have agreed to retain all the shares delivered in exchange for the contribution of their shares on the date of completion for a period of 12 months, and then, for an additional period of 24 months, up to a quota of 75%.